Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Journal of Biopharmaceutical Statistics
|
November 6, 2014
A simple and flexible graphical approach for adaptive group-sequential clinical trials
Toshifumi Sugitani, Frank Bretz, Willi Maurer
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
|
February 22, 2020
Clostridioides (Clostridium) difficile infection in Japanese hospitals 2008-2017: A real-world nationwide analysis of treatment pattern, incidence and testing density
Tomomi Kimura, Stephen Stanhope, Toshifumi Sugitani
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
|
April 17, 2019
Characterization and risk factors for recurrence of Clostridioides (Clostridium) difficile infection in Japan: A nationwide real-world analysis using a large hospital-based administrative dataset
Tomomi Kimura, Robert Snijder, Toshifumi Sugitani
Biometrical Journal. Biometrische Zeitschrift
|
April 12, 2013
Partition testing in confirmatory adaptive designs with structured objectives
Toshifumi Sugitani, Toshimitsu Hamasaki, Chikuma Hamada
Statistics in Medicine
|
June 27, 2018
Flexible alpha allocation strategies for confirmatory adaptive enrichment clinical trials with a prespecified subgroup
Toshifumi Sugitani, Martin Posch, Frank Bretz, et al.
Pharmaceutical Statistics
|
June 16, 2022
Confirmatory efficacy testing for individual dose-placebo comparisons using serial gatekeeping procedure in dose-finding trials with multiple comparison procedures-modeling
Yusuke Yamaguchi, Toshifumi Sugitani, Satoshi Yoshida, et al.
Clinical Drug Investigation
|
September 26, 2019
Open-Label Study to Assess the Efficacy of Ipragliflozin for Reducing Insulin Dose in Patients with Type 2 Diabetes Mellitus Receiving Insulin Therapy
Hisamitsu Ishihara, Susumu Yamaguchi, Toshifumi Sugitani, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
February 8, 2019
Characteristics of Patients with Diabetes Initiating Sodium Glucose Co-transporter-2 Inhibitors (SGLT2i): Real-World Results from Three Administrative Databases in Japan
Yuichiro Ito, James Van Schyndle, Takuya Nishimura, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
October 17, 2019
Real-World Effectiveness of Sodium Glucose Co-Transporter-2 Inhibitors in Japanese Patients with Diabetes Mellitus
Yuichiro Ito, James Van Schyndle, Takuya Nishimura, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
October 20, 2019
Drug Utilization Patterns in Patients with Diabetes Initiating Sodium Glucose Co-Transporter-2 Inhibitors (SGLT2i) in Japan: A Multi-Database Study (2014-2017)
Yuichiro Ito, James Van Schyndle, Takuya Nishimura, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Journal of Biopharmaceutical Statistics
|
November 6, 2014
A simple and flexible graphical approach for adaptive group-sequential clinical trials
Toshifumi Sugitani, Frank Bretz, Willi Maurer
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
|
February 22, 2020
Clostridioides (Clostridium) difficile infection in Japanese hospitals 2008-2017: A real-world nationwide analysis of treatment pattern, incidence and testing density
Tomomi Kimura, Stephen Stanhope, Toshifumi Sugitani
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
|
April 17, 2019
Characterization and risk factors for recurrence of Clostridioides (Clostridium) difficile infection in Japan: A nationwide real-world analysis using a large hospital-based administrative dataset
Tomomi Kimura, Robert Snijder, Toshifumi Sugitani
Biometrical Journal. Biometrische Zeitschrift
|
April 12, 2013
Partition testing in confirmatory adaptive designs with structured objectives
Toshifumi Sugitani, Toshimitsu Hamasaki, Chikuma Hamada
Statistics in Medicine
|
June 27, 2018
Flexible alpha allocation strategies for confirmatory adaptive enrichment clinical trials with a prespecified subgroup
Toshifumi Sugitani, Martin Posch, Frank Bretz, et al.
Pharmaceutical Statistics
|
June 16, 2022
Confirmatory efficacy testing for individual dose-placebo comparisons using serial gatekeeping procedure in dose-finding trials with multiple comparison procedures-modeling
Yusuke Yamaguchi, Toshifumi Sugitani, Satoshi Yoshida, et al.
Clinical Drug Investigation
|
September 26, 2019
Open-Label Study to Assess the Efficacy of Ipragliflozin for Reducing Insulin Dose in Patients with Type 2 Diabetes Mellitus Receiving Insulin Therapy
Hisamitsu Ishihara, Susumu Yamaguchi, Toshifumi Sugitani, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
February 8, 2019
Characteristics of Patients with Diabetes Initiating Sodium Glucose Co-transporter-2 Inhibitors (SGLT2i): Real-World Results from Three Administrative Databases in Japan
Yuichiro Ito, James Van Schyndle, Takuya Nishimura, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
October 17, 2019
Real-World Effectiveness of Sodium Glucose Co-Transporter-2 Inhibitors in Japanese Patients with Diabetes Mellitus
Yuichiro Ito, James Van Schyndle, Takuya Nishimura, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
October 20, 2019
Drug Utilization Patterns in Patients with Diabetes Initiating Sodium Glucose Co-Transporter-2 Inhibitors (SGLT2i) in Japan: A Multi-Database Study (2014-2017)
Yuichiro Ito, James Van Schyndle, Takuya Nishimura, et al.
Page
of 2